The CRC cells overexpressing ADAMTS9-AS2 showed less tumor volume (Figures 6(a) and 6(b)) and weight (Figure 6(c)) compared to controls, indicating that ADAMTS9-AS2 suppressed tumor growth. This evidence concerns the gene ADAMTS9 and colorectal carcinoma.